Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study

PURPOSE: Diabetes is a risk factor for COVID-19 severity, but the role played by glucose lowering medications (GLM) is still unclear. The aim of this study was to assess infection rates and outcomes of COVID-19 (hospitalization and mortality) in adults with diabetes assisted by the Local Health Unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannucci, Francesca, Vitturi, Giacomo, Benacchio, Luca, Sbrogiò, Luca Gino, Bano, Francesca, Lapolla, Annunziata, Piarulli, Francesco, Giron, Maria Cecilia, Avogaro, Angelo, Fadini, Gian Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553236/
https://www.ncbi.nlm.nih.gov/pubmed/36237966
http://dx.doi.org/10.2147/DMSO.S385646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553236/
https://www.ncbi.nlm.nih.gov/pubmed/36237966
http://dx.doi.org/10.2147/DMSO.S385646

Ejemplares similares